Arkolith/Insider Trading/ABCL/Form 4

Hansen Carl L. G.

Chief Executive Officer, Director, 10% OwnerAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Feb 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 22, 2023Option exercise(M)56K$2.70$152K505K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 22, 2023Option exercise(M)56K—$06.6M

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-012199) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML